Avantium N.V. (AMS:AVTX)

Market Cap	48.65M -68.7%
Revenue (ttm)	12.60M -32.9%
Net Income	-35.28M
EPS	-1.64
Shares Out	25.21M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,684,401
Open	1.950
Previous Close	2.120
Day's Range	1.880 - 1.990
52-Week Range	1.880 - 9.700
Beta	1.13
Analysts	Buy
Price Target	32.35 (+1,576.17%)
Earnings Date	Mar 17, 2027

About Avantium

Avantium N.V., a chemical technology company, develops and commercializes bio-based plastics and chemicals in the Netherlands. It operates through Avantium R&D Solutions and Avantium Renewable Polymers. The company offers Releaf, boasts barrier properties for carbon dioxide and oxygen that leads to longer shelf life of packaged products used for packaging, textiles, film, and PEF applications. It also provides furandicarboxylic acid (FDCA), a building block for the high-performance plant-based polymer polyethylene furanoate (PEF). In addition, ...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2000
• Employees: 245
• Stock Exchange: Euronext Amsterdam
• Ticker Symbol: AVTX

Financial Performance

In 2025, Avantium's revenue was 14.59 million, a decrease of -30.63% compared to the previous year's 21.04 million. Losses were -22.52 million, -16.19% less than in 2024.

Analyst Summary

According to 5 analysts, the average rating for AVTX stock is "Buy." The 12-month stock price target is €32.35, which is an increase of 1,576.17% from the latest price.

Price Target

€32.35

(1,576.17% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 11, 2026

Data Sources Report a data error